
Walgreens Boots Alliance Inc
NASDAQ:WBA

Intrinsic Value
The intrinsic value of one
WBA
stock under the Base Case scenario is
63.7
USD.
Compared to the current market price of 36.17 USD,
Walgreens Boots Alliance Inc
is
Undervalued by 43%.
The Intrinsic Value is calculated as the average of the two valuation methods:

Fundamental Analysis
WBA Profitability Score
Profitability Due Diligence
Walgreens Boots Alliance Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Walgreens Boots Alliance Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
WBA Solvency Score
Solvency Due Diligence
Walgreens Boots Alliance Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Walgreens Boots Alliance Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Balance Sheet Decomposition
Walgreens Boots Alliance Inc
WBA Capital Structure
Walgreens Boots Alliance Inc
Market Capitalization | 31.2B USD | |
Total Debt | 8.7B USD | |
Minority Interest | 4.2B USD | |
Preferred Equity | 0 USD | |
Cash and Equivalents | 2.3B USD | |
Short-Term Investments | 1.9B USD | |
Enterprise Value | 39.8B USD |
Wall St
Price Targets
WBA Price Targets Summary
Walgreens Boots Alliance Inc
According to Wall Street analysts, the average 1-year price target for
WBA
is 42.46 USD
with a low forecast of 36.36 USD and a high forecast of 56.7 USD.
Competitive Landscape
WBA Competitors
Walgreens Boots Alliance Inc
WBA Suppliers & Customers
Walgreens Boots Alliance Inc
Walgreens Boots Alliance Inc has 88 key suppliers from 10 countries and 20 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Real Estate industry.
Walgreens Boots Alliance Inc has 11 key customers from 4 countries and 6 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Health Care industry.
Ownership
WBA Insider Trading
Buy and sell transactions by insiders
During the last 12 months Walgreens Boots Alliance Inc insiders have not bought any shares, and sold 1.1M USD worth of shares. The last transaction was made on Feb 6, 2023 by Ban Kevin M. (EVP, Chief Medical Officer), who sold 414k USD worth of WBA shares.
Shareholder Return
WBA Price
Walgreens Boots Alliance Inc
Average Annual Return | -1.79% |
Standard Deviation of Annual Returns | 25.29% |
Max Drawdown | -59% |
Market Capitalization | 31.2B USD |
Shares Outstanding | 862 334 016 |
Percentage of Shares Shorted | 4.26% |
Company Profile

Country
Industry
Market Cap
Dividend Yield
Description
Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company is headquartered in Deerfield, Illinois and currently employs 202,000 full-time employees. The company went IPO on 2014-12-31. The firm operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the pharmacy-led health and beauty retail businesses and optical practices. The Pharmaceutical Wholesale segment consists of equity method investment in AmerisourceBergen. The firm's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots, as well as global health and beauty product brands, including No7, NICE!, Soap & Glory, Liz Earle, Finest Nutrition, Botanics, Well Beginnings, Sleek MakeUP and YourGoodSkin.
Contact
IPO
Employees
Officers
The intrinsic value of one
WBA
stock under the Base Case scenario is
63.7
USD.
Compared to the current market price of 36.17 USD, Walgreens Boots Alliance Inc is Undervalued by 43%.